Specialized facility for manufacturing oral fast dissolving thin strip dosage forms using Fast Disintegration Technology with 800,000 units/day capacity
Shilpa Therapeutics, a subsidiary of Shilpa Medicare Ltd., operates a specialized manufacturing facility dedicated to producing oral fast dissolving thin strip dosage forms using proprietary Fast Disintegration Technology.
This innovative facility represents our commitment to novel drug delivery systems, offering patients a convenient, fast-acting alternative to traditional oral dosage forms.
Proprietary technology for manufacturing oral fast dissolving thin strips
800,000 units per day capacity with 8-track packing machine
Aggressive capacity expansion initiatives underway for future growth
Oral disintegrating strips have received excellent response from both patients and prescribers across India, validating our innovative technology platform.
Building on this success, we continue to expand our product portfolio with additional therapeutic applications.
Explore more about our innovative oral thin film technology and product offerings by visiting the Shilpa Therapeutics website.
Visit Shilpa Therapeutics Website→